Sivik Global Healthcare’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-150,000
Closed -$4.25M 70
2019
Q1
$4.25M Buy
150,000
+93,814
+167% +$2.74M 1.57% 30
2018
Q4
$1.54M Sell
56,186
-38,814
-41% -$1.26M 0.83% 40
2018
Q3
$3.48M Sell
95,000
-65,000
-41% -$2.44M 1.24% 36
2018
Q2
$5.78M Hold
160,000
2.22% 20
2018
Q1
$6.59M Buy
160,000
+40,000
+33% +$1.71M 3.07% 6
2017
Q4
$5.08M Buy
+120,000
New +$4.59M 1.88% 22
2017
Q2
Sell
-60,000
Closed -$2.34M 74
2017
Q1
$2.34M Buy
+60,000
New +$2.42M 1.09% 36
2016
Q1
Sell
-90,000
Closed -$4.87M 66
2015
Q4
$4.87M Buy
90,000
+30,000
+50% +$1.44M 2.31% 15
2015
Q3
$2.42M Sell
60,000
-14,400
-19% -$803K 1.17% 33
2015
Q2
$5.05M Sell
74,400
-15,600
-17% -$1.1M 1.75% 19
2015
Q1
$5.34M Buy
90,000
+800
+0.9% +$45.6K 1.82% 18
2014
Q4
$5.03M Buy
+89,200
New +$4.79M 2.04% 17
2014
Q3
Sell
-75,000
Closed -$3.87M 80
2014
Q2
$3.87M Buy
75,000
+20,000
+36% +$983K 1.95% 23
2014
Q1
$2.69M Buy
+55,000
New +$2.67M 1.68% 27

Other funds holding VTRS

Sivik Global Healthcare's VTRS Position: Q2 2019 in Review

Sivik Global Healthcare sold out of Viatris (VTRS) in Q2 2019, closing a stake of 150,000 shares — an estimated $4.25M sold.

Sivik Global Healthcare first reported a position in VTRS in Q1 2014 and held it in 14 quarters. The position peaked at $6.59M in Q1 2018. 439 funds tracked by Wall St. Rank hold VTRS as of Q2 2019.

  • Sivik Global Healthcare reported no remaining Viatris position as of Q2 2019 after selling out during the quarter.
  • Sivik Global Healthcare sold 150,000 Viatris shares in Q2 2019, an estimated $4.25M.
  • Sivik Global Healthcare first reported a position in Viatris in Q1 2014 and held it in 14 quarters.
  • Sivik Global Healthcare's Viatris position peaked at $6.59M in Q1 2018.
  • 439 funds tracked by Wall St. Rank held Viatris as of Q2 2019.

Based on Sivik Global Healthcare's 13F filing for Q2 2019, filed 14 Aug 2019.